Mirum Pharmaceuticals reported revenue of $176.24M and net income of -$67.23M for the quarter ended Jun 2026, up 37.9% year over year. This income statement covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||
| Revenue | 5.00M | 3.14M | 12.89M | 17.48M | 18.78M | 27.91M | 31.60M | 37.50M | 47.73M | 69.55M | 69.22M | 77.88M | 90.38M | 99.41M | 111.58M | 127.78M | 133.01M | 148.93M | 159.88M | 176.24M | |||||||||||
| Cost of RevenueCost of Rev | 1.90M | 2.42M | 2.52M | 2.93M | 4.49M | 4.98M | 6.81M | 10.23M | 25.02M | 17.83M | 20.23M | 20.81M | 22.78M | 23.02M | 23.42M | 25.54M | 28.26M | 28.80M | 30.35M | ||||||||||||
| Gross Profit | 5.00M | 1.24M | 10.47M | 14.96M | 15.85M | 23.41M | 26.62M | 30.68M | 37.50M | 44.53M | 51.39M | 57.65M | 69.57M | 76.63M | 88.57M | 104.36M | 107.47M | 120.67M | 131.08M | 145.90M | |||||||||||
| Operating items | |||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 30.47M | 27.77M | 24.09M | 25.43M | 26.22M | 31.11M | 23.55M | 22.01M | 26.12M | 30.93M | 32.22M | 32.67M | 31.71M | 44.03M | 41.04M | 46.07M | 42.96M | 51.11M | 97.91M | 90.53M | |||||||||||
| Selling, General & AdministrativeSG&A | 17.35M | 19.04M | 19.12M | 20.97M | 22.51M | 26.47M | 30.22M | 32.95M | 36.53M | 46.18M | 45.64M | 49.21M | 50.55M | 56.83M | 57.71M | 63.29M | 61.91M | 74.13M | 96.33M | 81.47M | |||||||||||
| Other Operating ExpensesOther Opex | 1.90M | 2.42M | 2.52M | 2.93M | 4.49M | 4.98M | 6.81M | 10.23M | 25.02M | 17.83M | 20.23M | 20.81M | 22.78M | 28.02M | 23.42M | 25.54M | 28.26M | 755.11M | 46.78M | ||||||||||||
| Operating ExpensesOpex | 47.82M | 48.71M | 45.63M | 48.92M | 51.66M | 62.07M | 58.75M | 61.77M | 72.87M | 102.14M | 95.69M | 102.11M | 103.06M | 123.64M | 126.77M | 132.77M | 130.41M | 153.50M | 949.35M | 218.78M | |||||||||||
| Operating IncomeOp. Inc | -42.82M | -45.58M | -32.74M | -31.44M | -32.88M | -34.16M | -27.15M | -24.27M | -25.15M | -32.59M | -26.47M | -24.23M | -12.68M | -24.22M | -15.18M | -4.99M | 2.60M | -4.57M | -789.47M | -42.54M | |||||||||||
| EBIT | -42.82M | -45.58M | -32.74M | -31.44M | -32.88M | -34.16M | -27.15M | -24.27M | -25.15M | -32.59M | -26.47M | -24.23M | -12.68M | -24.22M | -15.18M | -4.99M | 2.60M | -4.57M | -789.47M | -42.54M | |||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 5.67M | 3.77M | 3.77M | 3.88M | 3.97M | 4.36M | 4.24M | 3.73M | 3.57M | 3.56M | 3.58M | 3.57M | 3.59M | 3.58M | 3.60M | 3.59M | 3.61M | 3.60M | 3.62M | 2.62M | |||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.07M | 0.07M | 0.07M | 0.29M | 1.35M | 2.14M | 2.27M | 3.63M | 4.06M | 3.77M | 3.63M | 3.49M | 3.47M | 3.20M | 3.02M | 3.03M | 3.25M | 3.42M | 3.40M | 3.85M | |||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.04M | -0.02M | -0.15M | 1.30M | -0.19M | -0.59M | -0.81M | -49.08M | 1.32M | 1.76M | 0.31M | -1.09M | 0.23M | 2.11M | 0.09M | 0.40M | -0.22M | -24.23M | |||||||||||||
| Net income details | |||||||||||||||||||||||||||||||
| EBT | -47.10M | 57.29M | -36.59M | -33.49M | -35.69M | -36.29M | -29.93M | -73.72M | -23.34M | -35.43M | -24.66M | -24.00M | -13.89M | -24.37M | -13.65M | -5.46M | 2.64M | -4.96M | -789.68M | -65.54M | |||||||||||
| Tax ProvisionsTaxes | 0.01M | 0.01M | 0.01M | -6.57M | 0.01M | 0.14M | 0.20M | 0.32M | 0.25M | 0.23M | 0.62M | 0.64M | 0.35M | -0.58M | 1.03M | 0.40M | -0.26M | 0.77M | 0.47M | 1.69M | |||||||||||
| Profit After TaxPAT | -47.11M | 57.55M | -36.61M | -26.92M | -35.71M | -36.43M | -30.13M | -74.04M | -23.59M | -35.66M | -25.28M | -24.64M | -14.23M | -23.79M | -14.68M | -5.86M | 2.90M | -5.73M | -790.15M | -67.23M | |||||||||||
| Income from Continuing OperationsIncome (Continuing) | -47.11M | 57.28M | -36.61M | -26.92M | -35.71M | -36.43M | -30.13M | -74.04M | -23.59M | -35.66M | -25.28M | -24.64M | -14.23M | -23.79M | -14.68M | -5.86M | 2.90M | -5.73M | -790.15M | -67.23M | |||||||||||
| Consolidated Net IncomeConsol Net Inc. | -47.11M | 57.28M | -36.61M | -26.92M | -35.71M | -36.43M | -30.13M | -74.04M | -23.59M | -35.66M | -25.28M | -24.64M | -14.23M | -23.79M | -14.68M | -5.86M | 2.90M | -5.73M | -790.15M | -67.23M | |||||||||||
| Income towards Parent CompanyParent Net Inc | -47.11M | 57.28M | -36.61M | -26.92M | -35.71M | -36.43M | -30.13M | -74.04M | -23.59M | -35.66M | -25.28M | -24.64M | -14.23M | -23.79M | -14.68M | -5.86M | 2.90M | -5.73M | -790.15M | -67.23M | |||||||||||
| Net Income towards Common StockholdersNet Income | -47.11M | 57.28M | -36.61M | -26.92M | -35.71M | -36.43M | -30.13M | -74.04M | -23.59M | -35.66M | -25.28M | -24.64M | -14.23M | -23.79M | -14.68M | -5.86M | 2.90M | -5.73M | -790.15M | -67.23M | |||||||||||
| Additional items | |||||||||||||||||||||||||||||||
| EPS (Basic) | -1.55 | 1.89 | -1.17 | -0.84 | -1.02 | -1.08 | -0.80 | -1.94 | -0.57 | -0.87 | -0.54 | -0.52 | -0.30 | -0.50 | -0.30 | -0.12 | 0.06 | -0.11 | -13.43 | -1.06 | |||||||||||
| EPS (Diluted) | -1.55 | 1.89 | -1.17 | -0.84 | -1.02 | -1.07 | -0.80 | -1.94 | -0.57 | -0.87 | -0.54 | -0.52 | -0.30 | -0.50 | -0.30 | -0.12 | 0.05 | -0.11 | -13.43 | -1.06 | |||||||||||
| Shares Outstanding | 30.37M | 30.32M | 31.30M | 32.16M | 34.93M | 33.84M | 37.68M | 38.11M | 41.10M | 40.89M | 46.93M | 47.24M | 47.78M | 47.52M | 48.89M | 49.73M | 50.64M | 50.20M | 58.85M | 63.37M | |||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 30.37M | 30.32M | 31.30M | 32.18M | 34.93M | 33.98M | 37.68M | 38.11M | 41.10M | 40.89M | 46.93M | 47.24M | 47.78M | 47.52M | 48.89M | 49.73M | 56.99M | 50.20M | 58.85M | 63.37M | |||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 30.41M | 30.58M | 31.71M | 32.69M | 36.81M | 36.96M | 38.01M | 38.22M | 46.60M | 46.72M | 47.06M | 47.57M | 47.97M | 48.34M | 49.45M | 50.06M | 51.31M | 51.90M | 60.93M | 64.75M | |||||||||||
| EBITDA | -42.82M | -45.58M | -32.74M | -31.44M | -32.88M | -34.16M | -27.15M | -24.27M | -25.15M | -32.59M | -26.47M | -24.23M | -12.68M | -24.22M | -15.18M | -4.99M | 2.60M | -4.57M | -789.47M | -42.54M | |||||||||||
| Interest ExpensesInt Expense | 5.67M | 3.77M | 3.77M | 3.88M | 3.97M | 4.36M | 4.24M | 3.73M | 3.57M | 3.56M | 3.58M | 3.57M | 3.59M | 3.58M | 3.60M | 3.59M | 3.61M | 3.60M | 3.62M | 2.62M | |||||||||||
| Tax Rate | -0.02% | 0.02% | -0.03% | 19.62% | -0.04% | -0.39% | -0.67% | -0.43% | -1.07% | -0.63% | -2.53% | -2.65% | -2.50% | 2.36% | -7.54% | -7.36% | -9.91% | -15.45% | -0.06% | -2.58% |